Intervention
Genetic testing
ClinicalTrials.gov intervention label
Clinical trials
7 shownTargeted Treatment for Metastatic Prostate Cancer, The PREDICT TrialNCT06632977 · 2025-02-06
RECRUITINGNeural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in AdolescentsNCT05437588 · 2022-10-01
RECRUITINGGenes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt LesionsNCT02691689 · 2015-11-01
RECRUITINGTherapeutic Monitoring of Drugs Used in the Treatment of Multiple SclerosisNCT05112484 · 2024-06-01
UNKNOWNEffectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast CancerNCT04354675 · 2021-06-29
COMPLETEDMolecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman DiseaseNCT05028621 · 2021-06-18
SUSPENDEDInvestigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.NCT03246841 · 2017-09-21
ACTIVE_NOT_RECRUITINGCommon conditions
Breast Cancer1Castleman's Disease (CD)1Castration-Resistant Prostate Carcinoma1Depression1Depression and Suicide1Depression in Adolescence1Depression, Teen1Genetic Testing1Heart Defects, Congenital1Hereditary Breast and Ovarian Cancer1Langerhans Cell Histiocytosis (LCH)1Major Depressive Disorder1MDD1Multiple Sclerosis1Mutation1Non-Langerhans-Cell Histiocytosis1Pulmonary Arterial Hypertension1Stage IVB Prostate Cancer AJCC v81Suicidal Ideas1Suicide1Suicide, Attempted1
Leading sponsors
Trial status mix
RECRUITING3
ACTIVE_NOT_RECRUITING1
COMPLETED1
SUSPENDED1
UNKNOWN1
Phase mix
NA5
PHASE21
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.